tiprankstipranks
Sundaram Multi Pap Limited (IN:SUNDARAM)
:SUNDARAM
India Market

Sundaram Multi Pap Limited (SUNDARAM) AI Stock Analysis

0 Followers

Top Page

IN:SUNDARAM

Sundaram Multi Pap Limited

(SUNDARAM)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
₹1.50
▼(-16.20% Downside)
Action:ReiteratedDate:03/28/26
The score is primarily constrained by weak technicals (downtrend across moving averages, negative MACD, oversold momentum) and pressured profitability (negative EBIT/net income). These are partly offset by balance-sheet strength (high equity ratio) and positive cash flow, while valuation appears moderate (P/E ~13.2) but lacks dividend support.
Positive Factors
Balance-sheet strength (high equity ratio)
A 72% equity ratio signals durable balance-sheet strength, providing resilience through cycles and greater borrowing flexibility. This capital structure supports investment or working-capital needs without excessive refinancing risk, sustaining operations over 2-6 months and beyond.
Negative Factors
Negative operating and net profitability
Sustained negative EBIT and net income weaken retained earnings and impair the firm's ability to reinvest. Over several months this reduces financial flexibility, may force cost cuts or restraint on growth initiatives, and elevates execution risk until profitability is restored.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet strength (high equity ratio)
A 72% equity ratio signals durable balance-sheet strength, providing resilience through cycles and greater borrowing flexibility. This capital structure supports investment or working-capital needs without excessive refinancing risk, sustaining operations over 2-6 months and beyond.
Read all positive factors

Sundaram Multi Pap Limited (SUNDARAM) vs. iShares MSCI India ETF (INDA)

Sundaram Multi Pap Limited Business Overview & Revenue Model

Company Description
Sundaram Multi Pap Limited designs, manufactures, and markets paper stationery products for students in India. It offers exercise note, long, scrap, drawing, graph, A4/A5/A3, college, hard bound, sketch, lekhan, practical, laboratory, pocket, six ...
How the Company Makes Money
null...

Sundaram Multi Pap Limited Financial Statement Overview

Summary
Balance sheet stability (72% equity ratio) and positive/free cash flow support the score, but it is held back by weak profitability (negative EBIT and net income, -4.02% net margin) and minimal revenue growth (0.29%).
Income Statement
55
Neutral
Balance Sheet
62
Positive
Cash Flow
68
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue1.28B1.27B1.27B1.14B703.58M505.92M
Gross Profit293.21M339.35M209.04M284.71M235.39M101.16M
EBITDA32.64M18.91M27.23M103.34M132.61M9.98M
Net Income-31.52M-51.21M-50.82M25.89M39.11M-88.35M
Balance Sheet
Total Assets1.00B1.22B1.35B1.38B1.46B1.48B
Cash, Cash Equivalents and Short-Term Investments168.07M211.03M2.23M26.04M3.63M4.47M
Total Debt211.52M268.68M333.90M346.19M393.68M446.90M
Total Liabilities319.38M340.64M419.45M403.71M510.26M567.60M
Stockholders Equity684.88M875.38M926.31M977.03M949.81M909.22M
Cash Flow
Free Cash Flow-66.30M68.89M34.87M108.36M49.50M52.54M
Operating Cash Flow-66.30M68.89M54.07M113.52M54.06M55.90M
Investing Cash Flow9.13M161.21M-19.35M-5.78M-3.18M19.99M
Financing Cash Flow-62.17M-90.21M-57.84M-86.03M-50.97M-80.95M

Sundaram Multi Pap Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.79
Price Trends
50DMA
1.45
Negative
100DMA
1.61
Negative
200DMA
1.81
Negative
Market Momentum
MACD
-0.02
Negative
RSI
56.38
Neutral
STOCH
89.56
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SUNDARAM, the sentiment is Neutral. The current price of 1.79 is above the 20-day moving average (MA) of 1.27, above the 50-day MA of 1.45, and below the 200-day MA of 1.81, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 56.38 is Neutral, neither overbought nor oversold. The STOCH value of 89.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:SUNDARAM.

Sundaram Multi Pap Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
57
Neutral
₹820.41M10.21
55
Neutral
₹668.17M13.24-0.92%9.65%
53
Neutral
₹691.84M106.63
37
Underperform
₹619.08M-0.7711.54%34.32%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SUNDARAM
Sundaram Multi Pap Limited
1.41
-0.67
-32.21%
IN:FCONSUMER
Future Consumer Limited
0.31
-0.19
-38.00%
IN:KLRF
Kovilpatti Lakshmi Roller Flour Mills Ltd
102.35
2.62
2.63%
IN:MHHL
Mohini Health & Hygiene Ltd.
40.05
-35.15
-46.74%
IN:PRITI
Priti International Ltd.
51.81
-40.00
-43.57%
IN:SPLIL
SPL Industries Limited
28.29
-6.17
-17.90%

Sundaram Multi Pap Limited Corporate Events

Sundaram Multi Pap Confirms SEBI Demat Compliance for March Quarter
Apr 8, 2026
Sundaram Multi Pap Limited has filed a compliance communication confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March 2026. The company informed the stock exchanges th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 28, 2026